title: 5-ASA therapy and renal function in inflammatory bowel disease.
authors.forename: Jens T
authors.initials: JT
authors.lastname: Siveke
authors.forename: Julia
authors.initials: J
authors.lastname: Egert
authors.forename: Thomas
authors.initials: T
authors.lastname: Sitter
authors.forename: Uwe
authors.initials: U
authors.lastname: Schiemann
authors.forename: Petra
authors.initials: P
authors.lastname: Walcher
authors.forename: Helga-Paula
authors.initials: HP
authors.lastname: Török
authors.forename: Jürgen
authors.initials: J
authors.lastname: Glas
authors.forename: Christian
authors.initials: C
authors.lastname: Folwaczny
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007674:Kidney Diseases / Q000139:chemically induced*; D019804:Mesalamine / Q000627:therapeutic use*; D009395:Nephritis, Interstitial / Q000139:chemically induced
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine